Author

A. U. Kabir

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1

Frequent Co-Authors

K. CHOI· 3 shared K. KRCHMA· 3 shared M. SUBRAMANIAN· 3 shared J. WU· 2 shared M. KIM· 2 shared B. Zinselmeyer· 1 shared C. M. HALABI· 1 shared C. Stewart· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. CHOI

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Zbtb46 coordinates angiogenesis and immunity to control tumor outcome

A. U. KABIR, M. SUBRAMANIAN, M. KIM, J. WU, K. KRCHMA, X. WANG, C. M. HALABI, H. PAN, S. A. WICKLINE, D. H. FREMONT, K. CHOI

This study identifies Zbtb46 as a regulator that coordinates angiogenesis and immunity in tumors, with its downregulation promoting a pro-tumor microenvironment and its restoration improving tumor outcomes.

bioRxiv · Mar 2, 2023 · PreprintCancer Biology

Interleukin-1α and Leukemia Inhibitory Factor Promote Extramedullary Hematopoiesis

D. Barisas, M. Kim, M. Subramanian, A. U. Kabir, K. Krchma, J. Wu, B. Zinselmeyer, C. Stewart, K. Choi

This study identifies IL-1 and LIF as factors promoting EMH by activating splenic niche cells and inducing an inflammatory gene signature in HSPCs.

bioRxiv · Jul 7, 2022 · PreprintImmunology

Conserved angio-immune subtypes of the cancer microenvironment predict response to immune checkpoint blockade therapy

M. Subramanian, A. U. Kabir, D. A. G. Barisas, K. Krchma, K. Choi

The paper identifies three conserved angio-immune subtypes in cancer microenvironments and shows that high immune activity with low angiogenesis correlates with better response to immune checkpoint blockade therapy.

bioRxiv · Dec 23, 2021Cancer Biology